Top Page
Acusensus Ltd
(Sydney:ACE)
Acusensus Ltd (ACE) vs. iShares MSCI Australia ETF (EWA)
Acusensus Ltd Business Overview & Revenue Model
Acusensus Ltd Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.84M | 59.35M | 49.63M | 42.00M | 28.65M | 6.27M |
| Gross Profit | 14.17M | 26.57M | 22.58M | 4.61M | 3.21M | -1.18M |
| EBITDA | -16.68M | 3.89M | 5.33M | 5.35M | 4.38M | -2.97M |
| Net Income | -22.93M | -2.62M | -1.52M | 55.37K | 1.43M | -3.65M |
Balance Sheet | ||||||
| Total Assets | 99.28M | 73.53M | 48.69M | 48.46M | 26.16M | 19.57M |
| Cash, Cash Equivalents and Short-Term Investments | 40.95M | 21.45M | 19.34M | 24.80M | 8.61M | 12.33M |
| Total Debt | 12.14M | 7.93M | 2.19M | 2.19M | 2.33M | 977.62K |
| Total Liabilities | 43.22M | 26.73M | 12.77M | 12.54M | 9.40M | 4.50M |
| Stockholders Equity | 56.06M | 46.79M | 35.92M | 35.92M | 16.76M | 15.07M |
Cash Flow | ||||||
| Free Cash Flow | -13.57M | -7.23M | -3.94M | -1.12M | -2.28M | -3.85M |
| Operating Cash Flow | 3.25M | 8.27M | 3.58M | 4.26M | 4.97M | -1.00M |
| Investing Cash Flow | 1.41M | -13.71M | -7.52M | -17.37M | -7.24M | -3.17M |
| Financing Cash Flow | 26.40M | 9.25M | -1.47M | 17.34M | -1.44M | 15.38M |
Acusensus Ltd Technical Analysis
Acusensus Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | AU$245.49M | -2.91 | -44.58% | ― | 19.60% | -59.17% | |
48 Neutral | AU$30.83M | -17.78 | -64.64% | 4.99% | -38.38% | -275.50% | |
44 Neutral | AU$4.32M | -0.75 | -53.27% | ― | 2.15% | -900.00% | |
43 Neutral | AU$5.52M | -3.48 | -658.94% | ― | 13.07% | 68.60% | |
42 Neutral | AU$6.38M | -1.21 | -15.64% | ― | -22.47% | 39.26% |
Acusensus Ltd Corporate Events
Acusensus Limited has been confirmed for inclusion in the S&P/ASX All Ordinaries Index as part of S&P Dow Jones Indices’ March 2026 quarterly rebalance, reinforcing its profile as a listed Australian road safety technology provider. The updated index changes, effective prior to the open on March 23, 2026, reverse earlier plans affecting African Gold Limited and American Rare Earths Limited, and bring a broad cohort of additional small and mid-cap resource, technology, and media companies into the benchmark, potentially impacting their visibility, liquidity, and appeal to index-tracking investors.
The decision to retain American Rare Earths and not add African Gold, alongside the inclusion of Acusensus and numerous other issuers, reflects ongoing adjustments to market capitalization and liquidity within the Australian equity universe. For Acusensus and its peers, All Ordinaries membership can support increased trading volumes and institutional attention, strengthening their standing in the domestic capital markets and potentially lowering the cost of capital over time.
The most recent analyst rating on (AU:ACE) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
S&P Dow Jones Indices has announced its March 2026 quarterly rebalance of the S&P/ASX indices, reshuffling constituents across the 20, 50, 100, 200 and 300 benchmarks, effective before the market opens on 23 March. The changes bring Northern Star Resources into the S&P/ASX 20 in place of Santos, introduce Light & Wonder and PLS Group to the S&P/ASX 50, expand gold and resources exposure in the S&P/ASX 100 and 200, and add a raft of smaller resource, technology and specialty names to the S&P/ASX 300, moves that are set to influence index-tracking fund flows and portfolio reweightings across the Australian equity market.
The most recent analyst rating on (AU:ACE) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Ltd has applied for quotation of 240,164 ordinary fully paid shares on the ASX under its existing ticker ACE. The new securities, issued on 4 March 2026 under an employee incentive scheme, will be quoted and freely transferable, modestly increasing the company’s free float and aligning staff interests with shareholders.
The move reflects Acusensus’s ongoing use of equity-based remuneration to incentivise employees within the constraints of ASX Listing Rules. While the issuance is relatively small, it incrementally broadens the company’s capital base and may support liquidity in trading of ACE shares over time.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus has expanded its fixed site multi-function enforcement agreement with Western Australia’s Road Safety Commission, adding new AI-enabled safety camera installations across the state from the second half of 2026 through 2027. The upgraded network will continue to detect offences such as illegal mobile phone use, seatbelt breaches, speeding, lane violations and unlicensed vehicles, strengthening the company’s role in digital road law enforcement.
The contract variation is expected to deliver approximately $11.2 million in additional revenue, excluding GST, and follows a separate $13 million expansion of Acusensus’ trailer-based enforcement program in the state earlier in the month. Together, the growing footprint of fixed and mobile systems underlines Acusensus’ deepening partnership with Western Australian authorities and reinforces its positioning as a key technology provider in the road safety enforcement sector, with implications for higher recurring revenues and stronger market credentials in similar jurisdictions.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus reported a 40% increase in half-year revenue to $40.3 million for the period ended 31 December 2025, driven by new enforcement contracts in New Zealand and Western Australia, higher unit deployments in Queensland and continued growth in the U.S. market. Despite the strong top-line performance, the company booked a net loss after tax of $20.8 million as higher operating costs to support expansion, strategic growth investments and $16 million in litigation settlement expenses weighed on profitability, while net tangible assets per share edged up to $0.33 and no dividend was declared for the period.
The inclusion of the Redflex Traffic Systems settlement within the latest half-year reflects a deliberate move to clear legacy legal overhangs in line with accounting standards and may help reduce uncertainty for investors in future periods. However, the expanded loss underlines the near-term margin pressures associated with Acusensus’ growth strategy, as the company balances international expansion and contract wins against the cost and risk profile of scaling its enforcement technology platforms.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Limited, a Melbourne-headquartered AI road safety technology provider, specialises in automated enforcement and monitoring systems that generate digital evidence for law enforcement and workplace protection, serving government and commercial clients across multiple international markets. The ASX-listed company has built a portfolio that includes distracted driving detection, compliance monitoring for road rules, and the Forsite road worker safety system integrating sensors, wearables, and real-time analytics.
The company announced it will release its financial results for the first half of FY26, covering the six months to 31 December 2025, on 26 February 2026. Management will host an investor webinar the same day to discuss the performance, signalling continued efforts to engage the market and provide transparency around the business trajectory, which may be closely watched by stakeholders given its growth ambitions in global road safety technology.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Limited has expanded and extended its multi-function road safety enforcement contract with Western Australia’s Road Safety Commission, doubling the number of trailer-based enforcement units deployed across the state. The new and existing trailers, which detect offences including mobile phone use, seatbelt breaches, speeding and unregistered vehicles, will be rolled out through September 2026, with the contract now running to at least October 2028 and delivering an incremental value of about $13 million, strengthening Acusensus’ recurring revenue base and its position in the road safety enforcement market.
The expanded fleet is expected to enhance regional coverage and support behavioural change on Western Australian roads by consolidating multiple enforcement functions into a single mobile platform. Management says the longer-term partnership underpins the effectiveness of Acusensus’ technology in improving road safety outcomes and reducing casualties, underscoring the company’s role as a key technology provider to government road safety authorities in Australia.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Ltd has notified the ASX of a proposed placement of up to 6,136,475 ordinary fully paid shares, with an expected issue date of 26 February 2026. The equity raising underscores the company’s continued use of share issuances to access capital, which may support future initiatives and growth, while signaling potential dilution for existing shareholders and a deepening of its engagement with equity markets.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Limited has reached a global settlement with Redflex Traffic Systems and its parent Verra Mobility, resolving Federal Court proceedings initiated in June 2025 over intellectual property disputes. Under the agreement, which involves no admission of liability by any party, Acusensus will provide a settlement package valued at AU$16 million to Verra Mobility subsidiary VM Consolidated, comprising AU$6 million in cash and 6,136,475 new Acusensus shares to be held in voluntary escrow for 12 months, with the litigation to be dismissed with no order as to costs. Crucially for its business model, Acusensus IP Pty Ltd retains ownership of its worldwide patent portfolio and will continue to use its technology unencumbered, while granting Redflex and its affiliates a global non-exclusive licence over relevant patents and securing mutual worldwide releases and a commitment from Redflex not to challenge the patents’ validity. The resolution removes a major legal and financial overhang for Acusensus, allowing the company to focus on expanding its road safety technology operations without ongoing litigation costs or uncertainty, while also bringing Verra Mobility onto its share register as a significant stakeholder.
The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Ltd has applied to the Australian Securities Exchange for quotation of 160,000 additional fully paid ordinary shares under the ticker ACE, to be issued on 7 January 2026. The small equity issuance, arising from the exercise or conversion of existing options or convertible securities, modestly increases the company’s quoted share capital and reflects ongoing utilisation of its equity-based instruments by holders.
The most recent analyst rating on (AU:ACE) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Ltd has issued a total of 36,483 unquoted performance rights (ASX code ACEAAA) under its employee incentive scheme, with 28,524 rights dated 8 December 2025 and 7,959 rights dated 20 November 2025, none of which are intended to be quoted on the ASX. The move reflects the company’s ongoing use of equity-based incentives to remunerate and retain staff and align employee interests with shareholder value, without altering its quoted share capital.
The most recent analyst rating on (AU:ACE) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Limited has issued 377,352 new fully paid ordinary shares following the exercise or conversion of previously unquoted equity securities, effective 2 December 2025. The issuance of these additional shares modestly expands the company’s share capital base and reflects the conversion of unquoted options or other convertible instruments, which may indicate employee or stakeholder incentives being realised and a further alignment of interests between management, staff and shareholders.
The most recent analyst rating on (AU:ACE) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.
Acusensus Limited has reported the lapse of 380,275 performance rights, which have ceased due to the relevant vesting conditions not being met or no longer being capable of being satisfied as at 31 December 2025. The cessation of these rights modestly reduces the company’s pool of potential equity-based remuneration and may slightly lessen prospective dilution for existing shareholders, while signalling that certain performance or service hurdles tied to these rights were not achieved within the prescribed timeframe.
The most recent analyst rating on (AU:ACE) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.